multiple sclerosis

Roche
Biotech

Roche unpacks death imbalance in multiple sclerosis ph. 3 trials

Deaths from infections, diabetes complications and an accident contributed to an imbalance between the fenebrutinib and control cohorts.
Nick Paul Taylor Apr 21, 2026 7:15pm
Completing steps towards success checkmark on cubes symbolizing progress

Roche reports pivotal MS win, but deaths add to safety questions

Mar 2, 2026 6:00am
Cargo shipping containers lost in ocean

Novartis jettisons ph. 1 cancer candidate after 0% efficacy

Feb 19, 2026 2:45pm
Completing steps towards success checkmark on cubes symbolizing progress

Roche unveils data behind BTK inhibitor's phase 3 MS win

Feb 9, 2026 7:00am
An envelope with rejected mark Vector illustration

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am
Stop sign

FDA rejects Sanofi MS drug, Corcept Cushing's syndrome therapy

Jan 2, 2026 7:10am